Polymers are ubiquitous to almost every aspect of modern society and their use in medical
products is similarly pervasive. Despite this, the diversity in commercial polymers used in …

PLGA microspheres are widely studied for controlled release drug delivery applications, and
many models have been proposed to describe PLGA degradation and erosion and drug …

Poly (lactic-co-glycolic acid)(PLGA) has been used for long-acting injectable drug delivery
systems for more than 30 years. The factors affecting the properties of PLGA formulations …

The hallmark of periodontal disease is the progressive destruction of gingival soft tissue and
alveolar bone, which is initiated by inflammation in response to an invasive and persistent …

The nascent field of biomimetic delivery with micro‐and nanoparticles (MNP) has advanced
considerably in recent years. Drawing inspiration from the ways that cells communicate in …

Ozurdex is a biodegradable implant formulated for sustained-release delivery of the
corticosteroid dexamethasone to the posterior segment of the eye. The small, rod-shaped …

A substantial drug release from poly (lactic-co-glycolic) acid (PLGA) micro-and nanoparticles
can occur in the first hours of immersion, which is referred to as burst release. A strong burst …

Monomer sequence is demonstrated to be a primary factor in determining the hydrolytic
degradation profile of poly (lactic-co-glycolic acid) s (PLGAs). Although many approaches …

Ozurdex is an FDA–approved sustained-release, biodegradable implant formulated to
deliver the corticosteroid dexamethasone to the posterior segment of the eye for up to 6 …

Controlling the backbone architecture of poly (lactic-co-glycolic acid) s (PLGAs) is
demonstrated to have a strong influence on the production and release of acidic …